Researchers will examine new treatments to improve outcomes for people with advanced kidney disease and those who have experienced an ischaemic stroke.
The research contributions of UNSW PhD student Dr Adeniyi Borire have been recognised by the American Association of Neuromuscular and Electrodiagnostic Medicine.
A drug that lowers blood sugar levels for people with type 2 diabetes has been revealed to also significantly reduce the risk of both cardiovascular and kidney disease.
